Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 6—June 2007

Economic Evaluation and Catheter-related Bloodstream Infections

Kate Halton*†Comments to Author  and Nicholas Graves*†
Author affiliations: *The Centre for Healthcare Related Infection Surveillance and Prevention, Brisbane, Queensland, Australia; †Queensland University of Technology, Brisbane, Queensland, Australia

Main Article

Table 6

Ranks of evidence for parameters used in the decision models*

Evidence ranking Clinical effectiveness of intervention, n = 8 Baseline incidence 
CR-BSI, n = 8 Attributable mortality,
n = 7 Incidence localized insertion site infection, n = 5 Cost of 
n = 8 Cost of intervention, n n = 8
High quality
  Rank 1 5 1 2
  Rank 2 1 1 1 1 7
Medium quality
  Rank 3 1 1 2
Low quality
  Rank 4 1 4 4 4 2
  Rank 5 1 1 1
  Rank 6
Unclear 1 1 1

*CR-BSI, catheter-related bloodstream infections.

Main Article

Page created: July 05, 2010
Page updated: July 05, 2010
Page reviewed: July 05, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.